← Open Payments lookup

JEVON JOHNSON: Open Payments

NPI 1154512036 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,512 in 50 payments from 10 companies in 2025. Trend: 2023 $8,252 · 2024 $8,245 · 2025 $1,512

Food & beverage: $1,301Education: $211
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.9$406
Alkermes, Inc.7$200
Otsuka America Pharmaceutical, Inc.9$186
ABBVIE INC.7$167
Janssen Pharmaceuticals, Inc4$119
Lundbeck LLC2$114
Vanda Pharmaceuticals Inc.3$113
E.R. Squibb & Sons, L.L.C.5$112
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$82
Luye Pharma (USA) Ltd.1$14

Products named: ARISTADA, VRAYLAR, AUSTEDO XR, REXULTI, INVEGA SUSTENNA, HETLIOZ, COBENFY, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.